| Literature DB >> 21418627 |
Donna Eldridge1, Nicky Dawber, Richard Gray.
Abstract
BACKGROUND: The risk of cardiovascular disease is increased in patients with severe mental illness (SMI) dramatically reducing life expectancy.Entities:
Mesh:
Year: 2011 PMID: 21418627 PMCID: PMC3070634 DOI: 10.1186/1471-244X-11-46
Source DB: PubMed Journal: BMC Psychiatry ISSN: 1471-244X Impact factor: 3.630
Baseline demographics
| n% | |
|---|---|
| Gender (% male) | 434 (55.5) |
| Ethnicity | |
| White | 733 (94) |
| Black | 13 (2) |
| Asian | 20 (3) |
| Other | 16 (2) |
| Age (mean s.d.) | 46.24 (12.4) |
s.d., standard deviation
Prescribed psychotropic medication (n = 794)
| Name/type of medicine | n (%) |
|---|---|
| Risperidone | 97 (12) |
| Olanzapine | 115 (14) |
| Quetiapine | 56 (7) |
| Amisulpride | 44 (6) |
| Aripirazole | 29 (4) |
| Clozapine | 83 (10) |
| Typical depot (Piportal, zuclopenthixol) | 107 (13) |
| Oral typical (sulpiride) | 83 (10) |
| Antidepressant (SSRIs/SNRIs) | 246 (31) |
| Antidepressant (TCAs/MAOIs) | 30 (4) |
| Sodium valproate, lithium, carbamazepine | 151 (19) |
| Benzodiazepine | 71 (9) |
| Anticholinergic | 74 (9) |
| Mean number of medicines per patient | 1.6 |
| Total number of medicines prescribed | 1186 |
SSRI, selective serotonin reuptake inhibitor; SNRI, serotonin-norepinephrine reuptake inhibitor; TCAs, tricyclic antidepressant; MAOI, monoamine oxidase inhibitor.
Cardiovascular risk factors at program and completion
| Total (program entry = 754; completion n = 159) | Differences (df) (completers only) | |||
|---|---|---|---|---|
| Program entry (n = 754,100%) | Program entry (completers n = 159, 20%) | Program completion (n = 159, 20%) | ||
| BMI | ||||
| <24.9 (normal) | 281 (37%) | 41 (28%) | 33 (26%) | χ2 = 126.01; df = 4; p < 0.01 |
| 25-29.9 (overweight) | 303 (40%) | 29 (20%) | 35 (28%) | |
| >30 (obese) | 198 (26%) | 76 (52%) | 59 (47%) | |
| Hypertension | ||||
| Normal BP (<140/85) | 494 (66%) | 103 (70%) | 88 (69%) | χ2 = 15.01; df = 1; p = <0.01 |
| Hypertension (>140/85) | 260 (34%) | 27 (30%) | 39 (31%) | |
| Cigarette smoking | ||||
| Smoker | 315 (48%) | 65 (41%) | 71 (45%) | ns |
| Non-smoker | 331 (51%) | 94 (59%) | 88 (55%) | |
| Alcohol | ||||
| Alcohol | 143 (22%) | 22 (14%) | 35 (22%) | ns |
| No-alcohol | 503 (78%) | 137 (86%) | 124 (78%) | |
| Substance use | ||||
| Cannabis use | 69 (11%) | 5 (3%) | 6 (4%) | ns |
| Other reported substance use (e.g. cocaine, ecstasy, heroin, amphetamine) | 38 (6%) | 8 (5%) | 7 (4%) | ns |
| Activity | ||||
| No regular activity | 284 (44%) | 72 (45%) | 62 (39%) | ns |
| Diet | ||||
| Unhealthy diet | 104 (16%) | 100 (63%) | 88 (55%) | ns |
| Average diet | 182 (28%) | 35 (22%) | 43 (27%) | |
| Healthy diet | 360 (56%) | 24 (15%) | 28 (18%) | |
| Self-esteem | ||||
| Low self-esteem | 330 (51%) | 93 (59%) | 82 (52%) | ns |
| Low/medium self-esteem | 104 (16%) | 30 (19%) | 30 (19%) | |
| Medium self-esteem | 181 (28%) | 32 (20%) | 42 (26%) | |
| Medium/high self-esteem | 22 (3%) | 4 (3%) | 3 (2%) | |
| High self-esteem | 9 (1%) | 0 (0%) | 2 (1%) | |
BMI, body mass index; χ2, chi squared test; ns, not significant.
Abnormal blood results at baseline
| Baseline | n (%) abnormal* | Mean (s.d.) | Range |
|---|---|---|---|
| Random glucose (normal 4-7 mmol/l), n = 138 | 26 (19%) | 5.57 (2.20) | 3.10-20.30 |
| Fasting glucose (normal 3.6-6.0 mmol/l), n = 39 | 8 (21%) | 5.45 (1.60) | 3.30-11.10 |
| HbA1c, n = 29 | 0 (0%) | 6.02 (1.43) | 4.60-12.80 |
| Triglyceride (reference range <2.0 mmol/l), n = 159 | 52 (32%) | 2.31 (1.63) | 0.50-10.50 |
| HDL cholesterol (reference ranges male 0.9 to 1.4; female 1.2 to 1.7 mmol/l), n = 178 | 52 (29%) | 1.34 (6.5) | 0.70-5.40 |
| LDL cholesterol (reference >4.0 mmol/l), n = 128 | 67 (52%) | 5.29 (1.27) | 1.80-9.00 |
| Aspartate Aminotransferase (AST-reference ranges, male 8-40 IU/l; female 6-34), n = 7 | 0 (0%) | 20.57 (4.79) | 13.00-26.00 |
| ALT (reference ranges male 10-50; female 5-38 IU/l), n = 180 | 16 (9%) | 27.91 (18.78) | 6.00-124.00 |
| Total bilirubin (reference range 3-17 | 3 (2%) | 9.27 (3.44) | 2.00-27.00 |
| Albumin (reference range 35 to 50 g/l), n = 189 | 0 (0%) | 42.43 (2.86) | 36.00-50.00 |
| Prolactin (mU/l; reference range 80-400 males; 90-520 females reproductive years; 80-280 females post menopausal), n = 129 | 22 (17%) | 454.26 (542.62) | 1.58-2862.00 |
| Free T4 (reference range 9-25 pmol/l), n = 159 | 1 (1%) | 14.37 (2.57) | 5.00-25.00 |
*of those patients tested
ALT, alanine transaminase; HbA1c, hemoglobin A1c; HDL, high density lipoprotein; LDL, low density lipoprotein; s.d., standard deviation; TSH, thyroid stimulating hormone.